IHE’s Sara Olofsson participates in JIMD Podcast about Arginase 1 deficiency

In the Podcast “Exploring the disease burden in Arginase 1 deficiency”, Sara talks about a study from IHE that has provided additional insights into the ultra-rare disease arginase 1 deficiency (ARG1-D), a metabolic disease which may cause spastic paraplegia, cognitive deficiency, seizures, and ultimately severe disability. The study showed that arginase 1 deficiency disease can cause severe cognitive and mobility impairment with impact on quality of life, societal costs, and caregiver burden. The study was a collaboration between IHE, Immedica Pharma AB and ARG1-D clinical expertise at hospitals in Europe and has been published in two scientific articles.

Here you can listen to the podcast:

Here you can read more about the study and download the two articles:

Societal costs and quality of life associated with arginase 1 deficiency in a European setting – a multinational, cross-sectional survey

Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross-sectional survey